Thus, TGF-β can activate HIF target genes in normoxic conditions and even more in hypoxic environments, so that they both contribute to further fuel these synergistic loops and promote the development of aggressive and invasive prostate cancer. Here, TGFB1 is linked to prostate carcinoma.